New mpox vaccine trial aims to protect High-Risk groups in colombia
⭐️ VACCINE ⭐️
Ongoing
This study tests whether the LC16m8 vaccine can prevent mpox (monkeypox) in about 8,700 adults at high risk, including those with HIV. Participants are randomly assigned to get the vaccine right away or after a delay. Researchers will compare infection rates and side effects betw…
Phase: PHASE3 • Sponsor: Universidad Nacional de Colombia • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 03:39 UTC